NeuroPace (NPCE) Interest Coverage Ratio Growth (1y) (2021 - 2026)
NeuroPace (NPCE) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 66.99% |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn | -53.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.13% |
| Dec 31, 2025 | 33.73% |
| Sep 30, 2025 | 18.72% |
| Jun 30, 2025 | -15.23% |
| Mar 31, 2025 | 28.46% |
| Dec 31, 2024 | 26.23% |
| Sep 30, 2024 | 28.39% |
| Jun 30, 2024 | 22.18% |
| Mar 31, 2024 | 21.07% |
| Dec 31, 2023 | 55.53% |
| Sep 30, 2023 | 49.25% |
| Jun 30, 2023 | 37.63% |
| Mar 31, 2023 | 20.64% |
| Dec 31, 2022 | -4.91% |
| Sep 30, 2022 | -56.51% |
| Jun 30, 2022 | -141.01% |
| Mar 31, 2022 | -154.60% |
| Dec 31, 2021 | -205.83% |
| Sep 30, 2021 | -718.67% |
| Jun 30, 2021 | -172.05% |